MedTrace Logo

Morbidity, Mortality And Risk Factors of Mpox in HIV Negative High Risk Sexual Health Clinic Attenders and People Living With HIV

NCT05965427 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-08-13

Study results available
· View outcomes & findings →

Summary

This data collection study aims to describe and compare the outcomes of Mpox on people living with HIV (PLHIV) and HIV-negative individuals who are on pre-exposure prophylaxis (PrEP). The study also aims to identify risk factors for specific Mpox outcomes.

Conditions

  • Monkeypox
  • HIV Coinfection

Interventions

OTHER

No intervention

Study is retrospective data collection only

Sponsors & Collaborators

  • European Commission

    collaborator OTHER

  • PENTA Foundation

    collaborator NETWORK

  • NEAT ID Foundation

    lead OTHER

Principal Investigators

  • Nicolo Girometti, MD · Chelsea and Westminster NHS Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2025-05-07
Completion
2025-05-07

Countries

  • France
  • Poland
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05965427 on ClinicalTrials.gov